AzTrials
AzTrials

Acute IllnessPhase 2NCT00178412

Improving Outcomes of Hospitalized Elders and Caregivers

A Phase 2 study testing Care Project for Hospitalized Elders & Family Caregivers and Comparison Group in people with Acute Illness, run by University of Rochester at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In this study, an intervention is tested that is designed to improve the outcomes of hospitalized elders and family caregivers. Study design: randomized, controlled study participants: 280 family caregivers aged 21 or above length of follow-up: 2 weeks and 2 months after hospitalization Study hypothesis: In this… Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Acute Illness
What is being tested?
Care Project for Hospitalized Elders & Family Caregivers and Comparison Group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
421 participants
Where
1 siteUnited States
Study dates
Apr 2003to Mar 2009
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • age of 21 years or above;
  • have an elderly relative (65 years or above) admitted to the three study units within the past 24-48 hours; (c) are related to the patient by blood, marriage, adoption, or affinity as a significant other (e.g., life partner, close friend);
  • are primary CGs;
  • can read and speak English; and
  • live within a 1-hour drive of the facility (60 miles).

Who cannot join

  • paid care providers;
  • unable to complete the questionnaires or provide care because of their own mental or physical impairment;
  • Patient:
  • dies during the hospital stay or within 2 months after discharge;
  • is transferred from the Intensive Care Unit (ICU) and stayed in the ICU for more than 2 nights;
  • is diagnosed with dementia;
Show all 9Show fewer
  • is admitted from a long-term care facility; and
  • is hospitalized for longer than 30 days
  • is staying longer than 6 weeks in a nursing home immediately after hospitalization.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Rochester School of Nursing

    Rochester, New York, 14642

Other trials in United States

About this study

In this study, an intervention is tested that is designed to improve the outcomes of hospitalized elders and family caregivers.

Study design:

Read more
  • randomized, controlled study
  • participants: 280 family caregivers aged 21 or above
  • length of follow-up: 2 weeks and 2 months after hospitalization

Study hypothesis: In this randomized clinical trial, the following hypotheses will be tested:

  1. Hospitalized elders whose family CGs receive the CARE program versus those who receive a comparison program will have better outcomes during and after hospitalization as measured by: (1) fewer incidents of dysfunctional syndrome; (2) shorter hospital stays; (3) lower readmission rates; (4) less depressive symptoms; (5) higher cognitive level; (6) less functional decline perceived by family CG; and (7) a closer relationship with their family CGs.
  2. Family CGs of hospitalized elders who receive the CARE program will report: (1) More positive beliefs about their loved one's responses to hospitalization and their role in the hospital setting; (2) more positive emotional outcomes (less worry, anxiety, and depressive symptoms) during and after hospitalization; (3) More participation in their loved one's care during hospitalization; and (4) More positive role outcomes (more role reward, less role strain, more prepared for their loved one's care, and a closer relationship with their elderly relatives, both during and after hospitalization).
  3. The proposed model to explain the effects of the CARE program on the process and outcomes of family CG coping and elderly patient outcomes will be supported for CGs and elderly patients.
Read the detailed description

More than 12 million elderly people are hospitalized each year in the United Status, frequently resulting in functional decline. Family care of hospitalized elders is important given the increasing numbers of hospitalized elders, needs for elder care in the home after hospital discharge, and responsibilities of family caregivers for providing this care. Involving family caregivers in the hospital care of their loved one may result in positive outcomes for both the elderly patients and their family caregivers. However, there is a paucity of empirical studies that have been conducted to evaluate the effectiveness of interventions to enhance family participation in caring for hospitalized elders. In the proposed study, we will build upon our prior work that has demonstrated the positive effects of theoretically-driven interventions with families of hospitalized patients and older adults at home. Among the unique contributions of this study include: (a) a randomized controlled design, (b) testing of a theoretically-driven, reproducible intervention that can be easily translated into clinical practice and widely disseminated; (c) the testing of an explanatory model to explain the effects of the intervention, (d) a prospective cost-effectiveness analysis; and (e) an intervention that begins early in the hospital stay, and (f) measurement of both short- and more long-term outcomes, up to 2 months following hospital discharge.

The primary aim of this study is to evaluate the effects of a theoretically-driven, reproducible intervention (CARE: Creating Avenues for Relative Empowerment) on the process and outcomes of hospitalized elders and their family caregivers. The secondary aims are to: (a) explore what factors moderate the effects of the intervention program (e.g., social economic status and family preferences for care participation); and (b) determine the cost-effectiveness of the CARE program. A two-group experiment will be used with 280 family caregivers of hospitalized elders. Measures of both process and outcome variables will be included, such as family caregiver beliefs, anxiety, worry, depression, role outcomes, as well as elderly patients outcomes during hospitalization and after hospital discharge. Findings from a recent pilot study with 49 family caregiver-elders dyads support undertaking this full-scale clinical trial in that family caregivers who received the CARE program, versus those who received a comparison program, had more positive coping and role outcomes and their hospitalized elderly relatives had positive outcomes during and after hospitalization.

Conditions
Acute Illness
Being tested
Care Project for Hospitalized Elders & Family Caregivers, Comparison Group
Keywords
Hospitalized elders, Family caregivers, Acute care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Care Project for Hospitalized Elders & Family CaregiversBehavioural

    Phase 1 in-hospital contact: Family caregivers complete baseline data, listen to a tape about helping the elderly relative cope with hospitalization, and work on a mutual agreement/identification of goals for participation in family member's hospital care (i.e., selection of two complications to focus on based on patient's illness condition)

    Phase 2 pre-hospital discharge: Family caregivers listen to a second tape about coping with the hospital experience, participating in their family member's in-hospital care, and preparing for hospital discharge/transition to home

  • Comparison GroupBehavioural

    Phase 1 in-hospital contact: Family caregivers complete baseline data and listen to an informational tape about hospital policies.

    Phase 2 pre-hospital discharge: Family caregivers listen to a second informational tape about the hospital and medical center.

Study groups in NCT00178412
Study groupRoleWhat they receive
1ExperimentalTreatment group
Receives: Behavioral: Care Project for Hospitalized Elders & Family Caregivers
2Active comparatorComparison Group
Receives: Behavioral: Comparison Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Patients' outcomes: rates of dysfunctional syndrome, readmission rate, and depression.

    Measured: At intake, 1-3 days pre-hospital discharge, at 2 weeks and at 2 months post hospital discharge

  2. Family Caregiver: emotional coping (worry, anxiety and depression); functional coping (participation in patient's care); and role outcomes(role reward, role strain)

    Measured: 1-3 days pre-hospital discharge, at 2 weeks and at 2 months post hospital discharge

Secondary outcomes (1)
  1. Cost analysis.

    Measured: At intake, 1-3 days pre-hospital discharge, at 2 weeks and at 2 months post hospital discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2005 (estimated)
  2. Study startApr 2003
  3. Primary completionApr 2006
  4. Study completionMar 2009

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
421 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00178412
Sponsor's protocol ID
R01NR008455-01
Other IDs
R01NR008455
Status last verified
Jun 2012
First submitted
12 Sep 2005
Last updated
14 Jun 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Li H, Melnyk BM, McCann R. Review of intervention studies of families with hospitalized elderly relatives. J Nurs Scholarsh. 2004;36(1):54-9. doi: 10.1111/j.1547-5069.2004.04011.x.

    PubMed 15098419
  • Li H, Melnyk BM, McCann R, Chatcheydang J, Koulouglioti C, Nichols LW, Lee MD, Ghassemi A. Creating avenues for relative empowerment (CARE): a pilot test of an intervention to improve outcomes of hospitalized elders and family caregivers. Res Nurs Health. 2003 Aug;26(4):284-99. doi: 10.1002/nur.10091.

    PubMed 12884417
  • Li H. Family caregivers' preferences in caring for their hospitalized elderly relatives. Geriatr Nurs. 2002 Jul-Aug;23(4):204-7. doi: 10.1067/mgn.2002.126966.

    PubMed 12183745
  • Li H. Hospitalized elders and family caregivers: a typology of family worry. J Clin Nurs. 2005 Jan;14(1):3-8. doi: 10.1111/j.1365-2702.2004.01013.x.

    PubMed 15656842
  • Li H. Identifying family care process themes in caring for their hospitalized elders. Appl Nurs Res. 2005 May;18(2):97-101. doi: 10.1016/j.apnr.2004.06.015.

    PubMed 15991107

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Care Project for Hospitalized Elders & Family Caregivers and Comparison Group in people with Acute Illness, run by University of Rochester at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jun 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Patients' outcomes: rates of dysfunctional syndrome, readmission rate, and depression. (time frame: At intake, 1-3 days pre-hospital discharge, at 2 weeks and at 2 months post hospital discharge). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00178412, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in